
Earnings brought the popcorn
U.S. Bancorp came out of Q1 looking sturdier than the usual regional-bank soap opera. Adjusted EPS landed at $1.18, ahead of the $1.14 Street guess, while revenue of $7.288 billion also edged past expectations. The stock liked what it heard, jumping 3.4% to $57.34 on Friday.
The real headline: the target shuffle
The earnings print wasn’t the only thing moving the tape. A handful of analysts walked away from the report and started recalibrating their models like they’d just found a better route on Waze:
- Truist kept a Buy and trimmed its target to $62 from $63
- RBC kept Outperform and lifted its target to $61 from $59
- Barclays stayed Overweight and raised its target to $67 from $65
- Oppenheimer kept Outperform and boosted its target to $73 from $71
That’s not exactly a standing ovation, but it’s a pretty clear message: the quarter gave the bull case a little extra breathing room.
Why investors should care
Management said it expects net interest income and fees to grow 6%–7% in Q2, and it’s guiding full-year revenue growth of 4%–6% with operating leverage north of 200 basis points. Translation: the bank thinks it can keep squeezing more juice out of the same orange, which is exactly what investors want to hear when they’re trying to decide whether this is a value trap or a slow-burn compounder.
Big picture: the quarter didn’t scream “moon mission,” but it did whisper “things are getting cleaner.” And in regional banking, that’s often enough to wake up the analysts.
